Marathon Venture Partners is a venture capital firm based in Beijing, China, specializing in investments in early and growth stage companies within the healthcare and financial technology sectors. The firm aims to support innovative businesses that are poised for significant growth, leveraging its expertise to identify and nurture promising opportunities in these dynamic industries. By focusing on healthcare and Fintech, Marathon Venture Partners seeks to contribute to advancements that can have a meaningful impact on society while delivering value to its investors.
Medical Image Insights is a company that specializes in medical imaging AI integration and R&D. It provide medical imaging professionals with AI and statistical-based medical imaging auxiliary tools, as well as its own medical imaging AI solutions.
Femtosecond Technology
Series A in 2024
Femtosecond Technology is a developer of label-free biological imaging technology.Femtosecond Technology is a high-tech, "specialized and innovative" firm focusing on the application of femtosecond laser technology in clinical diagnosis and treatment, as well as biomedical industrialization.
Natus
Seed Round in 2024
Nators specializes in precision motion positioning platforms, mechanical sensors, and nanoscience instruments, the company has developed precision positioning and sensing products for various applications, including optics, microscopy, and nano-level characterization and analysis. With a strong R&D capability and a complete production capacity, the company has become a partner of many domestic laboratories.
Kangai Medical
Series A in 2024
Kangai Medical specialises on clinical nutrition and rehabilitation
Minglan Shijia
Seed Round in 2023
Minglan Shijia focuses on the health of women's whole reproductive cycle and deeply cultivates the field of digital therapy in obstetrics and gynecology.
Bingjing Smart
Seed Round in 2023
Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascular interventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
Neowise
Series A in 2023
XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.
Botong Medical
Seed Round in 2023
Botong Medical is a comprehensive service platform created for the management of cancer pain. The business's data platform, digital medical goods, focuses on intelligent pain assessment, fracture risk prediction, chronic pain management, and rehabilitation. It offers stepped pain treatment services to both cancer pain patients and chronic pain patients.
Botong Medical
Angel Round in 2022
Botong Medical is a comprehensive service platform created for the management of cancer pain. The business's data platform, digital medical goods, focuses on intelligent pain assessment, fracture risk prediction, chronic pain management, and rehabilitation. It offers stepped pain treatment services to both cancer pain patients and chronic pain patients.
bio Genous
Seed Round in 2022
bio Genous provides biomedical scientific research, drug development, and clinical precision medicine services. They offer services that include organoid automation equipment, multi-tissue full-process kits, organoid culture and sample library construction technical solutions, organoid drug development, and precision medical subsystems.
SprintRay
Series D in 2022
SprintRay is a manufacturer of 3D printers specializing in digital dentistry, aimed at enhancing the capabilities of dental professionals. Since its inception in 2014, the company has focused on creating advanced and user-friendly products that enable dentists to respond swiftly to patient needs and broaden their treatment options. SprintRay's technology offers comprehensive additive manufacturing solutions that are designed to improve the efficiency of dental practices. By making 3D printing accessible and reliable, SprintRay seeks to transform the field of dentistry and expand the applications of desktop 3D printing into other industries.
Xunshi Technology
Series D in 2022
Zhejiang Xunshi Technology Co., Ltd. specializes in the development and manufacturing of 3D printers, printing consumables, and 3D scanners. The company offers a range of desktop printers tailored for specific sectors, including the MoonRay D for dental applications, MoonRay J for jewelry, and MoonRay S for educational purposes. Its industrial printer lineup features the SLA laser rapid prototyping printer, the SolarRay DLP 3D printer, and ceramic 3D printers such as the CeraRay CR-I and CeraRay TC-I. Additionally, Xunshi produces 3D architectural printers designed for contour crafting and provides photosensitive resin and photocurable wax products for dentistry, jewelry, and ceramics. The company's desktop scanners serve various applications in dental medicine, education, research, and industry. Established in 2013, Xunshi Technology is headquartered in Shaoxing, China.
Bingjing Smart
Angel Round in 2022
Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascular interventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
Bingjing Smart
Seed Round in 2022
Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascular interventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
Yuanyi Biotech
Seed Round in 2022
Yuanyi Biotech is specialized in creating artificial microbial technology and products. It designs and builds new gene metabolic pathways using "engineering" thinking and effective gene editing tools, creating cell factories with extremely high productivity, and offering one-stop solutions for integrated strain development, fermentation process optimization, industrial fermentation production, and product development.
Doctor AI Yisheng Intelligence
Series A in 2021
Doctor AI is a med-tech firm that provides a smart AI medical record quality control system.
AYR.ai
Series A in 2021
AYR.ai is an artificial intelligence platform that assists enterprises in transforming raw data into actionable insights. The platform leverages natural language processing, image processing, and predictive analytics to automate the entire life cycle of AI projects. This includes processes such as labeling, training, modeling, deploying, and maintaining AI solutions. By streamlining these tasks, AYR.ai enables businesses to implement practical, scalable, and cost-effective AI strategies, ultimately enhancing their operational efficiency and decision-making capabilities.
OrthoGuard
Series A in 2021
OrthoGuard Physicians is a comprehensive orthopedic medical service organization based in China, focusing on the treatment and diagnosis of various musculoskeletal conditions, including joint, spine, ankle, and trauma injuries. The company emphasizes efficient management and innovative operational models to enhance patient care, facilitating quicker healing and improved recovery experiences. In addition to direct medical services, OrthoGuard is involved in hospital management, rehabilitation services, and education and training initiatives. The organization also engages in supply chain management and the establishment of demonstration diagnosis and treatment centers, aiming to create a reputable and innovative medical group in the orthopedic field. Through these efforts, OrthoGuard seeks to leverage its extensive resources and expertise to advance orthopedic healthcare in China.
Lianbo Precision
Series A in 2021
Jiangsu Lianbo Precision Technology Co., Ltd., established in June 2008, specializes in the development and manufacturing of super-precision rotors and high-speed precision stamping components. With a production facility exceeding 30,000 square meters and a workforce of 200 employees, the company has an annual production capacity surpassing 60,000 tons and an output value reaching 500 million yuan. Lianbo Precision primarily serves the automotive industry, producing various types of rotors used in electric power steering, anti-lock braking systems, cooling fans, starters, and motors for new energy vehicles, as well as rotors for household appliances and industrial motors. The company imports advanced high-speed punching machines and testing equipment to enhance its manufacturing capabilities. Lianbo Precision's clientele includes renowned manufacturers from the United States, Japan, Germany, and France, demonstrating its commitment to providing professional support services to multinational corporations and global automotive parts enterprises.
Shangyong Technology
Series C in 2021
Shanghai Shangyong Technology focuses on delivering digital solutions tailored for life insurance risk management and health management services. The company has developed an insurance platform that leverages big data technology to create risk control models applicable to various insurance types, including life, critical illness, medical, and accident insurance. By quantifying health and credit risk levels, Shangyong Technology enables customers to access customized products that meet their specific needs. This approach enhances risk assessment and management within the insurance sector, providing valuable insights for both insurers and policyholders.
MediTrust Health
Series C in 2021
MediTrust Health is a leading healthcare platform in China that offers a wide range of health insurance products and comprehensive medical services. The company connects pharmaceutical companies, insurers, hospitals, and patients, creating a cohesive ecosystem that benefits all stakeholders involved. By integrating high-quality medical resources with health insurance, MediTrust Health aims to deliver affordable, personalized healthcare solutions to families. In addition to its insurance offerings, the company focuses on improving the management of medical expenses and enhancing patient access to necessary services through innovative payment solutions. MediTrust Health's commitment to addressing the complexities of medical financing and providing diverse healthcare benefits positions it as a significant player in the healthcare industry.
Connect Medical Value Technology
Series A in 2021
Connect Medical Value is a company based in Hangzhou, Zhejiang, China, that specializes in developing mobile applications for physicians. Founded in 2020, the company focuses on providing a comprehensive platform that integrates clinical services, scientific research, and educational resources. By leveraging advanced artificial intelligence technology, Connect Medical Value aims to enhance the capabilities of healthcare professionals, facilitating improved patient care and medical practice.
MediTrust Health
Series B in 2021
MediTrust Health is a leading healthcare platform in China that offers a wide range of health insurance products and comprehensive medical services. The company connects pharmaceutical companies, insurers, hospitals, and patients, creating a cohesive ecosystem that benefits all stakeholders involved. By integrating high-quality medical resources with health insurance, MediTrust Health aims to deliver affordable, personalized healthcare solutions to families. In addition to its insurance offerings, the company focuses on improving the management of medical expenses and enhancing patient access to necessary services through innovative payment solutions. MediTrust Health's commitment to addressing the complexities of medical financing and providing diverse healthcare benefits positions it as a significant player in the healthcare industry.
Singular Medical
Series B in 2021
Singular Medical is a technology company focused on the research, development, and industrialization of cardiac rhythm management (CRM) products. The company designs and develops a comprehensive range of high-quality medical devices, including implantable cardioverter defibrillators, pacemakers, and implantable cardiac monitors. Singular Medical aims to provide reliable and professional medical equipment that addresses the needs of a large population of cardiac patients, offering solutions that span from initial detection to ongoing follow-up care.
Singular Medical
Series A in 2020
Singular Medical is a technology company focused on the research, development, and industrialization of cardiac rhythm management (CRM) products. The company designs and develops a comprehensive range of high-quality medical devices, including implantable cardioverter defibrillators, pacemakers, and implantable cardiac monitors. Singular Medical aims to provide reliable and professional medical equipment that addresses the needs of a large population of cardiac patients, offering solutions that span from initial detection to ongoing follow-up care.
Xunshi Technology
Series B in 2019
Zhejiang Xunshi Technology Co., Ltd. specializes in the development and manufacturing of 3D printers, printing consumables, and 3D scanners. The company offers a range of desktop printers tailored for specific sectors, including the MoonRay D for dental applications, MoonRay J for jewelry, and MoonRay S for educational purposes. Its industrial printer lineup features the SLA laser rapid prototyping printer, the SolarRay DLP 3D printer, and ceramic 3D printers such as the CeraRay CR-I and CeraRay TC-I. Additionally, Xunshi produces 3D architectural printers designed for contour crafting and provides photosensitive resin and photocurable wax products for dentistry, jewelry, and ceramics. The company's desktop scanners serve various applications in dental medicine, education, research, and industry. Established in 2013, Xunshi Technology is headquartered in Shaoxing, China.
Ruiyi Biotechnology (Realbio Technology)
Series A in 2019
Shanghai Ruiyi Biotechnology Co., Ltd., established in 2014, is a national high-tech enterprise based in Shanghai, with additional branches in Hangzhou, Qingdao, and Guiyang. The company specializes in genetic technology and health services, focusing on microbial gene technology for tumor detection and intestinal microecology analysis. Ruiyi Biotechnology employs next-generation sequencing platforms and advanced computing capabilities to conduct extensive genetic research, sequencing, and bioinformatics analysis. It provides high-precision testing services in microbiota and oncology for healthcare practitioners and researchers. The company has formed partnerships with numerous renowned research institutes both domestically and internationally, and it has secured over 40 software copyrights along with several patents, attracting talent from genomics, medicine, and bioinformatics.
Shukun
Series B in 2019
Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.
Aqara
Series B in 2018
Aqara has emerged as a prominent brand in the smart home market, offering a diverse range of smart home appliances and IoT solutions tailored for both consumers and industrial applications. Known for their elegant design and high-quality products, Aqara aims to enhance daily living by simplifying routine tasks through innovative technology. The company's offerings leverage AI and data analysis, allowing customization to meet individual lifestyle requirements. With a strong emphasis on cost efficiency, Aqara consistently attracts consumers seeking reliable and stylish smart home solutions.
DaoCloud
Series B in 2018
DaoCloud, founded in late 2014, is a leader in the cloud-native technology sector, specializing in cloud-based docker container solutions. The company focuses on transforming how applications are created and delivered by providing a continuous integration toolchain that streamlines the development process from inception to final release. With a commitment to facilitating digital transformation for enterprises, DaoCloud leverages its proprietary intellectual property to offer an open Cloud Operating System. Its innovative approaches have been applied across various industries, including Fintech, advanced manufacturing, smart vehicles, retail, and urban intelligence initiatives.
GrandOmics
Series B in 2018
GrandOmics is a company that specializes in molecular diagnosis, research, and carrier screening for single-gene diseases. It offers comprehensive genetic testing services that are both scientific and accurate. The company has developed GrandBox, a suite of software designed for clinical sample management and data analysis, which facilitates the management and visualization of genetic disease sequencing data. GrandOmics employs single-molecule, real-time sequencing technology to enhance disease detection and provides a one-stop clinical data analysis platform for laboratories, ensuring efficient and precise data management in genetic research.
Shukun
Series A in 2018
Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.
Nanos Medical
Series B in 2018
Nanos Medical specializes in the research, development, manufacturing, and sales of disposable medical devices, primarily targeting the cardiovascular and ear, nose, and throat (ENT) fields. The company offers a range of innovative products, including sinus balloon catheters, eustachian tube balloons, disposable nasopharyngeal airways, nasolacrimal balloons, and drug-eluting stents for sinus applications. Through its advanced medical devices, Nanos Medical aims to enhance treatment options for hospitals and patients, contributing to improved healthcare outcomes.
Vedeng
Series A in 2018
Vedeng operates an online procurement platform that connects upstream manufacturers of medical devices with medical equipment dealers and private clinics. The company has developed a robust digital infrastructure that encompasses front-end marketing, procurement systems, logistics, after-sales service, and a comprehensive back-end database of commodities. This platform serves approximately 970,000 grassroots and private medical customers, facilitating efficient sourcing and distribution of medical equipment across China.
MediTrust Health
Angel Round in 2018
MediTrust Health is a leading healthcare platform in China that offers a wide range of health insurance products and comprehensive medical services. The company connects pharmaceutical companies, insurers, hospitals, and patients, creating a cohesive ecosystem that benefits all stakeholders involved. By integrating high-quality medical resources with health insurance, MediTrust Health aims to deliver affordable, personalized healthcare solutions to families. In addition to its insurance offerings, the company focuses on improving the management of medical expenses and enhancing patient access to necessary services through innovative payment solutions. MediTrust Health's commitment to addressing the complexities of medical financing and providing diverse healthcare benefits positions it as a significant player in the healthcare industry.
V-Joy Tech Group
Series A in 2018
V-Joy Tech is a provider of financial software designed specifically for the financial sector in China. The company offers solutions that focus on data management, data risk control, and payroll services, allowing clients to execute secure transactions. By addressing the unique needs of the financial industry, V-Joy Tech aims to enhance operational efficiency and ensure the integrity of financial data for its users.
Hofon Medical Care
Series A in 2018
Hofon Medical Care is a healthcare service provider dedicated to delivering comprehensive medical and health services to community residents. The company focuses on addressing the health needs and medical service demands of individuals in the community. It has developed an integrated online and offline service model that offers a range of services, including disease diagnosis and treatment, home-based medical care, chronic disease management, and health management. This approach aims to provide patients with convenient, efficient, and high-quality one-stop medical care close to their homes, enhancing accessibility to essential health services.
Huangjinguanjia
Series B in 2018
Huangjinguanjia is an online financial service platform based in Beijing, China, specializing in gold trading and investment. The company offers a range of financial services that facilitate the buying and selling of gold, catering to individuals and investors interested in this precious metal. Through its platform, Huangjinguanjia aims to provide users with accessible tools and resources for engaging in gold investment, contributing to the broader financial market in China.
Cihon Technology
Series B in 2018
Cihon is a digital intelligence service platform focused on the automotive industry. It offers data analytics on vehicles, auto parts, and vehicle owners, primarily catering to car manufacturers and insurance providers. By providing insights and analytics, Cihon enables these organizations to enhance their business operations and decision-making processes.
JuniperMD
Angel Round in 2018
JuniperMD Inc. is a disease management service organization based in Beijing, China, with additional locations in Guangzhou, Shanghai, New York, Boston, Chicago, and Houston. Founded in 2016, the company focuses on integrating medical resources from the United States, Australia, Japan, and Europe to enhance healthcare delivery in China. JuniperMD offers comprehensive disease management solutions that encompass overseas medical examinations, pathological assessments, remote diagnoses, consultations, and follow-up services. Their approach emphasizes prevention, investigation, diagnosis, and treatment. The company also engages in multidisciplinary dialogue, healthcare technology implementation, and second-opinion medical consultations, leveraging international physician partnerships to improve patient care and outcomes.
Lion Rock FinTech
Series A in 2017
Lion Rock FinTech is a startup company that provides commercial financing services. The company focuses on worldwide financial asset allocation and has built a financial services platform that incorporates fund sales, asset management, and financial media. It enables investors to obtain extensive information on wealth management products.
Yidebang
Series A in 2017
Yidebang is a Beijing-based healthcare software developer, which provides management solution, drug supply, hierarchical diagnosis and treatment and other supporting medical services for basic-level clinics in China.
AnchorDx
Series B in 2017
AnchorDx, also known as Guangzhou Baseline Medical, specializes in high-throughput sequencing technologies and molecular liquid biopsies, offering non-invasive access to genetic information. The company focuses on precision medicine and aims to be a leading global provider of medical solutions by leveraging its expertise in cancer genomics, genetics, and bioinformatics. With a core team possessing over 20 years of industry experience, AnchorDx collaborates with various downstream enterprises, hospitals, and research institutions to create an integrated industrial chain that facilitates the transformation of academic research into clinical products. The company is committed to developing independent intellectual property rights and competitive clinical testing products, thereby providing accurate and comprehensive services to patients, doctors, and medical institutions.
Helian Health
Series A in 2017
Helian Health, established in 2014 and based in Hangzhou, China, specializes in providing Wi-Fi services in hospitals and developing online healthcare applications for patients and healthcare professionals. The company offers platforms like Xiaohe Yizhu, which enables healthcare providers to manage health records in the cloud and exchange medical knowledge, and Hejiankang, which delivers personalized health recommendations for employees. Helian Health has secured partnerships with over 1,700 hospitals across 245 cities, serving more than 900 million outpatient visits. Its services extend to a modular user-centric design, including the Medicare Xiaobian Medical Aid APP, which aids medical staff with cloud access and clinical tools. The company is also focusing on Internet of Things (IoT) solutions in collaboration with prominent manufacturers to enhance operational efficiency in medical institutions. With its comprehensive approach, Helian Health aims to improve healthcare delivery and promote healthier lifestyles through technology-driven solutions.
Baozhunniu
Series B in 2017
Baozhunniu is an online insurance platform that specializes in providing customized insurance products to both enterprises and individuals. The company leverages a data-driven approach to overcome the limitations of the traditional insurance industry, offering tailored insurance plans that address a wide range of risks across various categories, including sports, employment, and international coverage. By focusing on innovative and flexible solutions, Baozhunniu aims to meet the unique needs of its clients in a rapidly evolving market.
Shukun
Angel Round in 2017
Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.
GEvent Financial Service
Series A in 2017
GEVent Financial Service is a financial services company based in Nanjing, China, specializing in providing a range of services to banks and non-bank financial institutions. The company offers bank wealth management services and facilitates asset management product exchanges through its internet-based platform. Additionally, it delivers financial and technical services, enabling financial institutions to access essential banking services, wealth management solutions, and technology-driven products. GEVent aims to enhance the operational efficiency and service offerings of its clients in the financial sector.
Ziasset Intelligent Technology
Angel Round in 2016
Ziasset Intelligent Technology is a technology-based company that has entered the financial sector with artificial intelligence as its core technology. It has remained committed to serving the financial market through artificial intelligence algorithms. The company intends to establish an artificial intelligence version of the domestic capital market as its foothold.
Yisheng Hui
Series A in 2016
Yisheng Hui is an Internet-based medical technology company with the objectives of increasing doctors' professional skills and sunshine income as its mission and helping doctors as its main strategic focus. Whether it's a clinical database, media matrix, live medical video broadcast, Doctor Connect APP, or community, doctors can increase their professional abilities and work efficiency in a variety of ways with the use of doctor tools, doctor-medical collaboration, and other dimensional requirements.
Hulianwang
Series A in 2016
Hulianwang is a provider of career development services intended for nursing professionals. The company offers professional and technical education for nurses, nursing career recruitment, study abroad programs, and academic advisory services, providing nurses with the tools necessary to begin their careers.
AnchorDx
Series A in 2015
AnchorDx, also known as Guangzhou Baseline Medical, specializes in high-throughput sequencing technologies and molecular liquid biopsies, offering non-invasive access to genetic information. The company focuses on precision medicine and aims to be a leading global provider of medical solutions by leveraging its expertise in cancer genomics, genetics, and bioinformatics. With a core team possessing over 20 years of industry experience, AnchorDx collaborates with various downstream enterprises, hospitals, and research institutions to create an integrated industrial chain that facilitates the transformation of academic research into clinical products. The company is committed to developing independent intellectual property rights and competitive clinical testing products, thereby providing accurate and comprehensive services to patients, doctors, and medical institutions.
GEvent Financial Service
Angel Round in 2014
GEVent Financial Service is a financial services company based in Nanjing, China, specializing in providing a range of services to banks and non-bank financial institutions. The company offers bank wealth management services and facilitates asset management product exchanges through its internet-based platform. Additionally, it delivers financial and technical services, enabling financial institutions to access essential banking services, wealth management solutions, and technology-driven products. GEVent aims to enhance the operational efficiency and service offerings of its clients in the financial sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.